Reaction Biology receives NIH grant award for epigenetic database

摘要

Reaction Biology Corporation (RBC) has been awarded a Phase I SBIR grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions. The grant will help fund an examination of the interaction ofover 140 0 FDA-Approved drugs and drug-like compounds with over 30 epigenetic modifying enzymes. The project will begin immediately at RBC's lab facilities, and will last for one year.